From: A cross-sectional internet-based patient survey of the management strategies for gout
Patient characteristics | Patient preference for choice of ULT as the treatment for gouta | Urate-lowering medication adherence >80Â %b | Likelihood of diet changec |
---|---|---|---|
Gender | P = 0.04 | P = 0.21 | P = 0.15 |
   Male | 0.64 (0.42, 0.98)* | 0.62 (0.29, 1.31) | 0.74 (0.50, 1.12) |
   Female | Ref | Ref | Ref |
Age groups | P = 0.32 | P = 0.78 | P = 0.02 |
   21–40 | 0.83 (0.24, 2.87) | 0.89 (0.84, 9.44) | 2.89 (0.58, 14.25) |
   41–60 | 1.01 (0.32, 3.20) | 1.32 (0.15, 11.52) | 2.84 (0.61, 13.10) |
   61–80 | 0.69 (0.22, 2.21) | 1.58 (0.18, 13.96) | 4.86 (1.05, 22.57)* |
   >80 | Ref | Ref |  |
Race | P = 0.49 | P = 0.66 | P = 0.32 |
   African American | 0.86 (0.43, 1.72) | 0.49 (0.11, 2.23) | 1.50 (0.77, 2.94) |
   Hispanic or Latino | 0.92 (0.31, 2.71) | 0.94(0.11, 8.31) | 0.93 (0.31, 2.82) |
   Asian | 0.55 (0.29, 1.03) | 2.20(0.83, 5.80) | 0.61(0.30, 1.21) |
   American Indian or Alaskan native | ----- | ----- | 3.34 (0.30, 37.15) |
   Hawaiian or Pacific Islander | 4.14 (0.50, 34.7) | 1.17 (0.13, 10.85) | 2.09 (0.55, 7.90) |
   Other | 0.86 (0.33, 2.24) | 1.88(0.35, 10.10) | 1.67 (0.65, 4.31) |
   White/Caucasian | Ref | Ref | Ref |